Gene therapy to drive viral and biologics market, says SAFC episode artwork

EPISODE · Oct 13, 2009 · 6 MIN

Gene therapy to drive viral and biologics market, says SAFC

from The Biopharma Pod · host William Reed Ltd

SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.

SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.

NOW PLAYING

Gene therapy to drive viral and biologics market, says SAFC

0:00 6:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Biopharma Pod?

This episode is 6 minutes long.

When was this The Biopharma Pod episode published?

This episode was published on October 13, 2009.

What is this episode about?

SAFC Pharma has added extra viral and biologics capacity at its California plant in a $12m project that allows it to take projects from the lab to commercial scale.

Can I download this The Biopharma Pod episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!